1. Home
  2. PRCT vs PTA Comparison

PRCT vs PTA Comparison

Compare PRCT & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$17.56

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest

PTA

Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest

SELL

Current Price

$16.82

Market Cap

942.4M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
PRCT
PTA
Founded
2009
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
942.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
PRCT
PTA
Price
$17.56
$16.82
Analyst Decision
Hold
Analyst Count
15
0
Target Price
★ $22.25
N/A
AVG Volume (30 Days)
★ 1.3M
305.9K
Earning Date
11-04-2026
01-01-0001
Dividend Yield
N/A
★ 8.31%
EPS Growth
★ 1.71
N/A
EPS
★ N/A
N/A
Revenue
★ $308,054,000.00
N/A
Revenue This Year
$28.32
N/A
Revenue Next Year
$20.48
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 37.22
N/A
52 Week Low
$16.67
$16.66
52 Week High
$38.11
$20.15

Technical Indicators

Market Signals
Indicator
PRCT
PTA
Relative Strength Index (RSI) 45.00 34.17
Support Level $16.84 N/A
Resistance Level $29.27 $19.59
Average True Range (ATR) 0.99 0.25
MACD 0.12 -0.01
Stochastic Oscillator 35.14 14.95

Price Performance

Historical Comparison
PRCT
PTA

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

About PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest

COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its main investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.

Share on Social Networks: